CC Chemours Q4 2025 EPS falls short of estimates shares rise 135 percent on slight year over year revenue growth Sangoma SANG Q1 earnings miss widens significantly with loss per share at 6 cents versus 328 cents estimate stock slides 1 percent NBIS Nebius beats Q4 2025 EPS expectations sharply revenue soars amid booming AI infrastructure demand Is Pacira BioSciences PCRX stock risky Marginal Gain 20260420 DIAX Nuveen Dow30 discloses no core quarterly earnings data leaving investors waiting for further operational updates Warren Buffetts Tiny Purchase Hint Berkshire Hathaway Filing May Reveal Mystery Investment Inspired Entertainment INSE Delivers Q1 2026 Beat EPS 002 vs 011 Expected Retail Sales Data Signals Continued Consumer Resilience Pembina PBA Q1 2026 Earnings Beat Revenue NA EPS 081 Trainline Raises FullYear Guidance for Second Time in 2026 Inflation Rate Projected to Hit 6 in the Second Quarter Top Economic Forecasters Say Bankruptcy in Singapore Overspending and Business Failures Drive Rising Personal Insolvency Cases Greg Abels Potential 142 Billion Stock Purchase Signals Berkshire Succession Strategy DeepSeek Panic Overstated US AI Giants May Weather Competitive Storm SpaceX Confidential IPO Filing Paves Way for Potential Stock Market Debut Under Ticker SPCX Petraeus Suggests Iran May Concede on Strait of Hormuz in Potential Peace Deal